Prognosis in Infective Endocarditis

  • Isidre Vilacosta
  • Carmen Olmos Blanco
  • Cristina Sarriá Cepeda
  • Javier López Díaz
  • Carlos Ferrera Durán
  • David Vivas Balcones
  • Luis Maroto Castellanos
  • José Alberto San Román Calvar


Despite diagnostic and therapeutic improvements, infective endocarditis remains associated with high mortality and severe complications. When assessing the prognosis of patients with endocarditis, three different clinical periods should be distinguished: prognostic assessment at admission, early risk reassessment during the first week of antibiotics, and short and long-term prognosis after discharge. The three cornerstones for diagnosis and prognosis of patients with endocarditis are based on physical examination (signs of heart failure), echocardiography (periannular complications), and blood cultures (S. aureus infection). These predictors can be available in the first 72 h after admission. Besides the above mentioned three clinical periods, for those patients who require surgical treatment in the active phase of the disease, an accurate surgical risk score would help to recognize which patients have a high risk and should not be sent to surgery.


Left-sided endocarditis Prognosis Heart failure Periannular complications Risk score Surgery 


  1. 1.
    Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–413.PubMedCrossRefGoogle Scholar
  2. 2.
    Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32(16):2027–33.PubMedCrossRefGoogle Scholar
  3. 3.
    Chu VH, Cabell CH, Benjamin Jr DK, Kuniholm EF, Fowler Jr VG, Engemann J, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109(14):1745–9.PubMedCrossRefGoogle Scholar
  4. 4.
    San Román JA, López J, Vilacosta I, Luaces M, Sarriá C, Revilla A, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007;120(4):369.e1–7.CrossRefGoogle Scholar
  5. 5.
    Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis. Risk classification for mortality. JAMA. 2003;289(15):1933–40.PubMedCrossRefGoogle Scholar
  6. 6.
    Granowitz E, Longworth DL. Risk stratification and bedside prognostication in infective endocarditis. JAMA. 2003;289(15):1991–3.PubMedCrossRefGoogle Scholar
  7. 7.
    Mansur AJ, Grinberg M, Cardoso HA, da Luz PL, Bellotti G, Pileggi F. Determinants of prognosis in 300 episodes of infective endocarditis. Thorac Cardiovasc Surg. 1996;44(1):2–10.PubMedCrossRefGoogle Scholar
  8. 8.
    Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, CooK D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638–52.PubMedCrossRefGoogle Scholar
  11. 11.
    Ferrera C, Vilacosta I, Fernández C, López J, Sarriá C, Olmos C, et al. Usefulness of thrombocytopenia at admission as a prognostic marker in native valve left-sided infective endocarditis. Am J Cardiol. 2015;115(7):950–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Sy RW, Chawantanpipat C, Richmond D, Kritharides L. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol. 2008;51(18):1824–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Nadji G, Rusinaru D, Remadi JP, Jeu A, Sorel C, Tribouilloy C. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009;11(7):668–75.PubMedCrossRefGoogle Scholar
  14. 14.
    Olmos C, Vilacosta I, Fernández C, López J, Sarriá C, Ferrera C, et al. Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Eur Heart J. 2013;34(26):1999–2006.PubMedCrossRefGoogle Scholar
  15. 15.
    García-Cabrera E, Fernández-Hidalgo N, Almirante B, Ivanova-Georgieva R, Noureddine M, Plata A, et al. Neurological complications of infective endocarditis. Risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127(23):2272–84.PubMedCrossRefGoogle Scholar
  16. 16.
    Delahaye F, Alla F, Beguinot I, Bruneval P, Doco-Lecompte T, Lacassin F, et al. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis. 2007;39(10):849–57.PubMedCrossRefGoogle Scholar
  17. 17.
    Duval X, Alla F, Doco-Lecompte T, Le Moing V, Delahaye F, Mainardi JL, et al. Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality. Eur Heart J. 2007;28(1):59–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Gelsomino S, Maessen JG, van der Veen F, Livi U, Renzulli A, Lucà F, et al. Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. Ann Thorac Surg. 2012;93(5):1469–76.PubMedCrossRefGoogle Scholar
  19. 19.
    Olmos C, Vilacosta I, Pozo E, Fernández C, Sarriá C, López J, et al. Prognostic implications of diabetes in patients with left-sided endocarditis: findings from a large cohort study. Medicine (Baltimore). 2014;93(2):114–9.CrossRefGoogle Scholar
  20. 20.
    López J, Revilla A, Vilacosta I, Sevilla T, Villacorta E, Sarriá C, et al. Age-dependent profile of left-sided infective endocarditis. A 3-center experience. Circulation. 2010;121(7):892–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am. 2001;15(2):407–21.PubMedCrossRefGoogle Scholar
  22. 22.
    Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906–12.PubMedCrossRefGoogle Scholar
  23. 23.
    Movahed MR, Hashemzadeh M, Jamal MM. Increased prevalence of infectious endocarditis in patients with type II diabetes mellitus. J Diabetes Complications. 2007;21(6):403–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102(23):2842–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F, et al. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis. 2010;19(3):312–20.PubMedGoogle Scholar
  26. 26.
    Kourany WM, Miro JM, Moreno A, Corey GR, Pappas PA, Abrutyn E, et al. Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database. Scand J Infect Dis. 2006;38(8):613–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care. 2001;24(6):1044–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler Jr VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med. 2009;169(5):463–73.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Mourviller B, Trouillet JL, Timsit JF, Baudot J, Chastre J, Regnier B, et al. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med. 2004;30(11):2046–52.CrossRefGoogle Scholar
  30. 30.
    Parrino PE, Kron IL, Ross SD, Shockey KS, Kron AM, Towler MA, et al. Does a focal neurologic deficit contraindicate operation in a patient with endocarditis? Ann Thorac Surg. 1999;67(1):59–64.PubMedCrossRefGoogle Scholar
  31. 31.
    Chou M-T, Wang J-J, Wu W-S, Weng S-F, Ho C-H, Lin Z-Z, et al. Epidemiologic features and long-term outcome of dialysis patients with infective endocarditis in Taiwan. Int J Cardiol. 2015;179:465–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Maraj S, Jacobs LE, Maraj R, Kotler MN. Bacteremia and infective endocarditis in patients on hemodialysis. Am J Med Sci. 2004;327(5):242–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Hoen B. Infective endocarditis: a frequent disease in dialysis patients. Nephrol Dial Transplant. 2004;19(6):1360–2.PubMedCrossRefGoogle Scholar
  34. 34.
    Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int. 1999;55(3):1081–90.PubMedCrossRefGoogle Scholar
  35. 35.
    Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci. 2003;325(4):237–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Shroff GR, Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis. 2004;44(6):1077–82.PubMedCrossRefGoogle Scholar
  37. 37.
    Jones DA, McGill LA, Rathod KS, Matthews K, Gallagher S, Uppal R, et al. Characteristics and outcomes of dialysis patients with infective endocarditis. Nephron Clin Pract. 2013;123(3–4):151–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Fernández-Cean J, Álvarez A, Burguez S, Baldovinos G, Larre-Borges P, Cha M. Infective endocarditis in chronic hemodialysis: two treatment strategies. Nephrol Dial Transplant. 2002;17(12):2226–30.PubMedCrossRefGoogle Scholar
  39. 39.
    Leither MD, Shroff GR, Ding S, Gilbertson DT, Herzog CA. Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States. Circulation. 2013;128(4):344–51.PubMedCrossRefGoogle Scholar
  40. 40.
    Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation. 2002;105(11):1336–41.PubMedCrossRefGoogle Scholar
  41. 41.
    Thuny F, Habib G. When should we operate on patients with acute infective endocarditis? Heart. 2010;96(11):892–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Vilacosta I, Graupner C, San Román JA, Sarriá C, Ronderos R, Fernández C, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol. 2002;39(9):1489–95.PubMedCrossRefGoogle Scholar
  43. 43.
    López J, Sevilla T, Vilacosta I, Sarriá C, Revilla A, Ortiz C, et al. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J. 2013;34(23):1749–54.PubMedCrossRefGoogle Scholar
  44. 44.
    Revilla A, López J, Vilacosta I, Villacorta E, Rollán MJ, Echevarría JR, et al. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J. 2007;28(1):65–71.PubMedCrossRefGoogle Scholar
  45. 45.
    Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA. 2003;290(24):3207–14.PubMedCrossRefGoogle Scholar
  46. 46.
    Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007;44(3):364–72.PubMedCrossRefGoogle Scholar
  47. 47.
    Mestres CA, Castro MA, Bernabeu E, Josa M, Cartaná R, Pomar JL, et al. Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results. Eur J Cardiothorac Surg. 2007;32(2):281–5.PubMedCrossRefGoogle Scholar
  48. 48.
    Rasmussen RV, Bruun LE, Lund J, Larsen CT, Hassager C, Bruun NE. The impact of cardiac surgery in native valve infective endocarditis: can EuroSCORE guide patient selection? Int J Cardiol. 2011;149(3):304–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Wang TKM, Oh T, Voss J, Gamble G, Kang N, Pemberton J. Comparison of contemporary risk scores for predicting outcomes after surgery for infective endocarditis. Heart Vessels. 2014;30(2):227–34.PubMedCrossRefGoogle Scholar
  50. 50.
    Shahian DM, O’Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of thoracic surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2–22.PubMedCrossRefGoogle Scholar
  51. 51.
    Gaca JG, Sheng S, Daneshmand MA, O’Brien S, Scott Rankin J, Matthew Brennan J, et al. Outcomes for endocarditis surgery in North America: A simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141(1):98–106.PubMedCrossRefGoogle Scholar
  52. 52.
    De Feo M, Cotrufo M, Carozza A, De Santo LS, Amendolara F, Giordano S, et al. The need for a specific risk prediction system in native valve infective endocarditis surgery. Sci World J. 2012;2012:307571.Google Scholar
  53. 53.
    Martínez-Sellés M, Muñoz P, Arnáiz A, Moreno M, Gálvez J, Rodríguez-Roda J, et al. Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis. Int J Cardiol. 2014;175(1):133–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis. A prospective study from the International Collaboration on Endocarditis. Circulation. 2015;131(2):131–40.PubMedCrossRefGoogle Scholar
  55. 55.
    Olmos C, Vilacosta I, Sarriá C, Fernández C, López J, Ferrera C, et al. Characterization and clinical outcome of patients with possible infective endocarditis. Int J Cardiol. 2015;178:31–3.PubMedCrossRefGoogle Scholar
  56. 56.
    Chee Q-Z, Tan Y-QB, Ngiam JN, Win MTM, Shen X, Choo J-NJ, et al. The SHARPEN clinical risk score predicts mortality in patients with infective endocarditis: An 11-year study. Int J Cardiol. 2015;191:273–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Mirabel M, Sonneville R, Hajage D, Novy E, Tubach F, Vignon P, et al. Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis. Eur Heart J. 2014;35(18):1195–204.PubMedCrossRefGoogle Scholar
  58. 58.
    Shih C-J, Chu H, Chao P-W, Lee Y-J, Kuo S-C, Li S-Y, et al. Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study. Circulation. 2014;130(19):1684–91.PubMedCrossRefGoogle Scholar
  59. 59.
    Gálvez-Acebal J, Almendro-Delia M, Ruiz J, de Alarcón A, Martínez-Marcos FJ, Reguera JM, et al. Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: a multicenter cohort study. Mayo Clin Proc. 2014;89(10):1397–405.PubMedCrossRefGoogle Scholar
  60. 60.
    Alagna L, Park LP, Nicholson BP, Keiger AJ, Strahilevitz J, Morris A, et al. Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect. 2014;20(6):566–75.PubMedCrossRefGoogle Scholar
  61. 61.
    Kaiser SP, Melby SJ, Zierer A, Schuessler RB, Moon MR, Moazami N, et al. Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg. 2007;83(1):30–5.PubMedCrossRefGoogle Scholar
  62. 62.
    Heiro M, Helenius H, Makila S, Hohenthal U, Savunen T, Engblom E, et al. Infective endocarditis in a finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart. 2006;92(10):1457–62.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Heiro M, Helenius H, Hurme S, Savunen T, Metsärinne K, Engblom E, et al. Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years. BMC Infect Dis. 2008;8:49.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Fedoruk LM, Jamieson WR, Ling H, MacNab JS, Germann E, Karim SS, et al. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg. 2009;137(2):326–33.PubMedCrossRefGoogle Scholar
  65. 65.
    David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg. 2007;133(1):144–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–132.PubMedCrossRefGoogle Scholar
  67. 67.
    Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96.PubMedCrossRefGoogle Scholar
  68. 68.
    Martínez-Sellés M, Muñoz P, Estevez A, del Castillo R, García-Fernández MA, Rodríguez-Creixems M, et al. Long-term outcome of infective endocarditis in non-intravenous drug users. Mayo Clin Proc. 2008;83(11):1213–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Fernández-Hidalgo N, Almirante B, Tornos P, González-Alujas MT, Planes AM, Galiñanes M, et al. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect. 2012;18(12):E522–30.PubMedCrossRefGoogle Scholar
  70. 70.
    Thuny F, Giorgi R, Habachi R, Ansaldi S, Le Dolley Y, Casalta JP, et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J. 2012;164(1):94–101.PubMedCrossRefGoogle Scholar
  71. 71.
    Mokhles MM, Ciampichetti I, Head SJ, Takkenberg JJ, Bogers AJ. Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg. 2011;91(5):1407–12.PubMedCrossRefGoogle Scholar
  72. 72.
    Ternhag A, Cederstrom A, Torner A, Westling K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One. 2013;8(7):e67519.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32(16):2003–15.PubMedCrossRefGoogle Scholar
  74. 74.
    Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis. 2011;11:48.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Isidre Vilacosta
    • 1
  • Carmen Olmos Blanco
    • 1
  • Cristina Sarriá Cepeda
    • 2
  • Javier López Díaz
    • 3
  • Carlos Ferrera Durán
    • 1
  • David Vivas Balcones
    • 1
  • Luis Maroto Castellanos
    • 1
  • José Alberto San Román Calvar
    • 3
  1. 1.Department of CardiologyHospital Clínico San CarlosMadridSpain
  2. 2.Department of Internal Medicine and Infectious DiseasesHospital Universitario de la PrincesaMadridSpain
  3. 3.Instituto de Ciencias Del Corazón (ICICOR)Hospital Clínico Universitario de ValladolidValladolidSpain

Personalised recommendations